MYVOIZA

View On IPO.GOV.AU

Cancelled: Cancelled at the request of IB

Last updated on 12 Feb 2025

Owner Info

Vertex Pharmaceuticals Incorporated

50 Northern Avenue

Boston MA 02210, UNITED STATES OF AMERICA

Serial Number

2235026 filed on 9 Nov 2021

Correspondent

Timothy H. Hiebert Womble Bond Dickinson (US) LLP

470 Atlantic Ave.,

Boston MA 02210-2228,

UNITED STATES OF AMERICA

MYVOIZA

Classification Information

2235026

9 Nov 2021

WORD

28 Oct 2021

Status Date	Action Taken
12^th Feb 2025	Status change to Voided
8^th Jun 2022	International Registration in Australia Protected correspondence sent
7^th Jun 2022	IP Right Registration Published
7^th Jun 2022	Status change to Registered/Protected
29^th Mar 2022	Application Accepted correspondence sent
29^th Mar 2022	IP Right has been Examined
29^th Mar 2022	IP Right Acceptance Published
15^th Dec 2021	Status change to Accepted
14^th Dec 2021	Examination expedited
14^th Dec 2021	Awaiting examination